Selective estrogen receptor downregulators (SERDs)
Results Trial description recap V1

Fulvestrant


Advanced breast cancer (metastatic)

all type of patients 18 trials

patients recurring or progressing after prior endocrine therapy 7 trials

first line endocrine therapy 5 trials

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons